Dr. Albert Català Temprano is a distinguished specialist in Pediatric Oncology and Hematology, contributing his expertise to the SJD Barcelona Children’s Hospital since 2018. Renowned for his proficiency in Oncological hematology and bone marrow failure, Dr. Albert's commitment extends to both medical research and patient treatment. His academic journey includes a Degree in Medicine from the University of Barcelona in 2000, followed by specialization in General Pediatrics at the SJD Barcelona Children’s Hospital in 2005. Driven by a passion for pediatric hematology/oncology, he pursued a Masters in the field from 2006 to 2008, ultimately completing his Doctor of Medicine degree from the University of Barcelona in 2017. Dr. Albert Català Temprano's professional trajectory highlights his dedication to advancing medical knowledge. His fellowship in bone marrow failure and pediatric myelodysplastic syndrome at the Hospital for Sick Children, Canada (2017-2018), exemplifies his commitment to international collaboration and cutting-edge research. Since 2015, he has served as the Principal Investigator of the Clinical Group Linked to CIBERER Carlos III Health Institute, contributing significantly to the understanding of pediatric hematological disorders. As the Spanish coordinator of the European Working Group, overseeing areas such as Myelodysplastic Syndromes in Childhood, Myelomonocytic Leukemia, and Severe Aplastic Anemia (EWOG), Dr. Albert remains at the forefront of advancements in the field. His memberships in esteemed organizations, including the research team of bone marrow failure of the Spanish Society of Pediatric Hematology and Oncology (SEHOP) and the team at the Hospital Sant Joan de Déu Research Institute, underscore his commitment to collaborative and impactful research.